Stay updated on TERN-501 and TERN-101 in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-501 and TERN-101 in NASH Clinical Trial page.

Latest updates to the TERN-501 and TERN-101 in NASH Clinical Trial page
- Check2 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating access is blocked and the prior content is no longer accessible.SummaryDifference18%

- Check44 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, reflecting a newer internal version of the page and not altering study details or how the study information is presented.SummaryDifference0.0%

- Check66 days agoChange DetectedThe sponsor line now specifies the full corporate entity providing information, and the revision label was updated to v3.6.5, reflecting a new page version.SummaryDifference0.3%

- Check80 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page, indicating a version update to the study detail page. The study information and layout appear unchanged.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page updates its liver disease terminology by swapping Fatty Liver Disease for Steatotic Liver Disease in its glossary. This reflects a terminology alignment in the page’s contextual descriptions.SummaryDifference0.0%

Stay in the know with updates to TERN-501 and TERN-101 in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-501 and TERN-101 in NASH Clinical Trial page.